MoA Signed for commercial packaging of LPB-ELISA kit

16th June 2015, New Delhi

Agrinnovate India Limited and M/s Arsh biotech Pvt Ltd, New Delhi entered into a Memorandum of Agreement for commercial packaging of “liquid phase blocking- ELISA (LPB-ELISA) kit” developed by ICAR-Project Directorate on Foot & Mouth Disease, Mukteshwar on 16 June, 2015 in presence of Dr. S. Ayyappan, Secretary DARE and Director General, ICAR. The commercialisation of ELISA Kit will ensure easy availability of the kits in coming years in the country.

MoA Signed for commercial packaging of LPB-ELISA kitMoA Signed for commercial packaging of LPB-ELISA kit

A Memorandum of Understanding was also signed between ICAR-National Institute of Veterinary Epidemiology and Disease Informatics, Agrinnovate India Ltd. and M/s Arsh Biotech Pvt. Ltd., New Delhi for transfer of technology and collaborative research in the area of Brucellosis disease.

The licensing would not only meet the diagnostic requirements of the country but also will contribute to National FMD & Brucellosis control programme of Government of India.

Senior officials of ICAR Headquarters and respective Institutes participated in the event.

(Source: Agrinnovate India Limited, New Delhi)